Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
With a market cap of 152.83B, Abbott(ABT) trades at $87.66. The stock has a price-to-earnings ratio of 23.85 and currently yields dividends of 2.9%.
On 2026-06-01, Abbott(ABT) stock moved within a range of $85.14 to $87.93. With shares now at $87.66, the stock is trading +3.0% above its intraday low and -0.3% below the session's peak.
Trading volume for Abbott(ABT) stock has reached 10.56M, versus its average volume of 11.55M.
The stock's 52-week range extends from a low of $81.97 to a high of $139.06.
The stock's 52-week range extends from a low of $81.97 to a high of $139.06.
ABT News
Analyst David Roman from Goldman Sachs maintained a Buy rating on Abbott Laboratories and decreased the price target to $113.00 from $121.00. Claim 55% Off TipR...
Earlier this week, the American Cancer Society updated its colorectal cancer screening guidelines, reaffirming Abbott’s Cologuard and Cologuard Plus as preferre...
In the past year, shares of Boston Scientific BSX and Abbott Laboratories ABT have lost 53% and 35%, respectively, significantly underperforming the S&P 500’s 3...
Analyst ratings
77%
of 30 ratingsMore ABT News
Abbott Laboratories (ABT) is back in focus after winning European clearance for its Libre Duo glucose ketone sensors and securing approval for its Ultreon 3.0 A...
Abbott Laboratories (NYSE:ABT) secured US and European clearance for its Ultreon 3.0 AI-powered coronary imaging platform, aimed at improving decision support d...
Abbott (ABT) ended the recent trading session at $113.04, demonstrating a -0.69% swing from the preceding day's closing price. The stock's performance was behin...
Abbott (ABT) announced it has secured CE Mark for the world’s first dual glucose-ketone sensing technology for people with diabetes. Branded as Libre Duo and Li...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.